CHERRY Aktie 112129002 / DE000A3CRRN9
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
13.08.2025 13:49:04
|
EQS-News: Cherry SE reschedules the publication of its 2025 half-year report
|
EQS-News: CHERRY SE
/ Key word(s): Half Year Report
Munich, 13 August 2025 – Cherry SE announced today that it is rescheduling the publication of its half-year report from 14 August to 26 September 2025. The reason for the postponement is the pending clarification regarding the down payments from the divestment of its hygiene business. The publication of the 2025 half-year report, originally scheduled for 14 August, has been postponed to 26 September. The reason for the delay is the pending final clarification of the closing accounts underlying the purchase price in connection with the divestment of the hygiene peripheral devices business ("Active Key") and the resulting final settlement of the down payments received in May against the immediately due portion of the purchase price. At the same time, the rescheduling allows for the early involvement of Jurjen Jongma, who will assume the role of CFO as of 1 September 2025, in shaping the company’s future outlook. A detailed breakdown of key preliminary figures for the second quarter and first half of 2025, as well as the H1 webcast from 31 July, is available on the company’s website at https://ir.cherry.de/en/home/publications/#presentations-webcasts.
About Cherry SE Cherry SE [ISIN: DE000A3CRRN9] is a global manufacturer of computer input devices such as keyboards, mice, microphones, and headsets for applications in office, gaming, and industry for hybrid work, as well as hardware and software solutions in digital healthcare. Since its founding in 1953, CHERRY has been synonymous with innovative and durable high-quality products, developed in-house, specifically to meet customer needs. CHERRY’s operational headquarters is in Germany (Auerbach in der Oberpfalz) and it employs staff in development, services, logistics, and production sites in Germany (Auerbach), China (Zhuhai), and Austria (Vienna), as well as in multiple sales offices in Germany (Munich, Auerbach), France (Paris), Sweden (Landskrona), the USA (Kenosha), China (Shanghai) and Taiwan (Taipei). For more information, visit: https://ir.cherry.de/en/
Contact Cherry SE
13.08.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Cherry SE |
| Rosental 7, c/o Mindspace | |
| 80331 Munich | |
| Germany | |
| ISIN: | DE000A3CRRN9 |
| WKN: | A3CRRN |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2183494 |
| End of News | EQS News Service |
|
|
2183494 13.08.2025 CET/CEST